Navigation Links
Applying math to cancer, climate, crime and cameras
Date:3/5/2014

Improving radiation therapies for cancer mathematically

In a paper published in December in the SIAM Journal on Scientific Computing, authors Li-Tien Cheng, Bin Dong, Chunhua Men, Xun Jia, and Steve Jiang propose a method to optimize radiation therapy treatments in cancer patients.

Radiation therapy is one of the primary methods used for cancer treatment, along with chemotherapy and surgery. While doses of radiation are delivered to eliminate cancerous tissue, care is taken to keep radiation within acceptable levels so as not to affect neighboring tissues and organs. The most common type of therapy delivers high-energy radiation via a medical linear accelerator mounted on a rotating apparatus to adjust the direction, and a collimator to shape the beam of radiation. In the recently developed volumetric modulated arc therapy (VMAT), beams continuously deliver doses as the delivery device rotates around the patient. Enhancement of radiotherapy treatment is challenged by complexities of shape optimization, due to the mechanics of the equipment involved as well as the apertures of devices delivering the beams of radiation.

In this paper, the authors develop a variational model and associated numerical techniques for optimization of VMAT treatment plans. The method uses CT scans of patientswith important tissues and organs identified by image segmentation algorithmsto create an improved and customized treatment plan by constructing parameters for an optimal dose distribution in VMAT treatment. Mathematical methods such as binary level-set method for shape optimization are used. Tests have shown improved dose distributions in both model and clinical cases.

Binary Level-Set Shape Optimization Model and Algorithm for Volumetric Modulated Arc Therapy in Radiotherapy Treatment

SIAM Journal on Scientific Computing,
'/>"/>

Contact: Karthika Muthukumaraswamy
karthika@siam.org
267-350-6383
Society for Industrial and Applied Mathematics
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Antiviral enzyme contributes to several forms of cancer, University of Minnesota researchers say
2. National Institutes of Health to fund research probing proteins linked to cancer, diabetes
3. UT Southwestern scientists make mouse model of human cancer, demonstrate cure
4. Vitamin D holds promise in battling a deadly breast cancer, Saint Louis University researchers say
5. Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets
6. Mushroom-derived compound lengthens survival in dogs with cancer, Penn Vet study finds
7. Nevada climate, environmental data network to inform research, community
8. Changing climate, not tourism, seems to be driving decline in chinstrap-penguin populations
9. Research warns Asia unlikely to achieve climate, poverty goals unless womens rights are recognized
10. JRC and US NOAA enhance cooperation on climate, weather, oceans and coasts
11. Pacific islands may become refuge for corals in a warming climate, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/24/2015)... VIEW, Calif. , Aug. 24, 2015  Based on ... Sullivan recognizes DERMALOG with the 2015 African Biometrics Company of ... and has achieved substantial commercial success in Africa ... Nigeria , where it has implemented one of the ... 23 banks as well as the Central Bank of ...
(Date:8/19/2015)... 2015  VOXX International Corporation (Nasdaq: VOXX ... a Definitive Agreement to purchase the assets, inclusive ... leader EyeLock through an acquiring entity.  Upon consummation ... interest in the acquiring entity. The closing of ... diligence.  Expanding on its existing supply chain and ...
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2
... Human impacts on the environment have reduced populations ... is this more apparent than in worldwide fisheries, ... species and populations of fish are on the ... mitigate the dire situation, captive breeding, the controlled ...
... top food scientist at Queen,s University Belfast is playing a ... techniques to detect chemical contaminants in food and animal feed. ... and Land Use at Queen,s, will lead a team of ... from potentially fatal toxins in a wide range of foods ...
... A University of Iowa study provides insight into a ... irregular heartbeats and other critical functions. The researchers showed ... contributes to arrhythmia in an extremely rare disease called ... heartbeats. The findings, which involved a new ...
Cached Biology News:Queen's University Belfast plays leading role in Europe-wide tests for safer food 2Rare disease provides clues about enzyme role in arrhythmias 2Rare disease provides clues about enzyme role in arrhythmias 3
(Date:8/26/2015)... WARREN, N.J. , Aug. 26, 2015  Roka ... company focused on providing advanced testing solutions for the ... Thomas, CEO will present at the Sidoti & Company ... The conference will be held at the New York ... the presentation will be available through the investor relations ...
(Date:8/26/2015)... -- Intrexon Corporation (NYSE: XON ), a leader ... previously announced public offering of common stock, including the ... to purchase an additional 731,707 shares of common stock ...  The exercise of the underwriters, option brought the total ... to 5,609,756 shares and increased the total gross proceeds ...
(Date:8/26/2015)... , August 26, 2015 ... biggest factors fueling the optimism in biotech,s forecast ... collaborations and life sciences advancements.  Active biotechnology & ... Pressure BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: ... SRPT ), Raptor Pharmaceutical Corp. (NASDAQ: RPTP ...
(Date:8/25/2015)... ... August 25, 2015 , ... ... lesions are cancerous is described by University of Illinois researchers in the ... and photonics. , In “ Breast cancer diagnosis using spatial light interference microscopy ...
Breaking Biology Technology:Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... Hovione announced today the,launch of its new ... in-depth and up-to-date information on the Hovione Group., ... structure organized,into four Business Units: Generics, Exclusives, Particle ... comprehensive, however,information is easy to find and navigation ...
... 16 NexGenix Pharmaceuticals, presented,data on its Hsp90 ... the AACR,in San Diego today. The company presented ... of several novel, radicicol-based,Hsp90 inhibitors in its compound ... tumor xenograft models,without evidence for liver and kidney ...
... ARUP Laboratories, a national,clinical and anatomic pathology reference ... announced today that,company co-founder Carl R. Kjeldsberg, MD, will ... June 2009. Kjeldsberg has held the position,since 1993 and ... of,the Board., Effective, July 1, 2009, Edward R. ...
Cached Biology Technology:NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect 2NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect 3ARUP Laboratories CEO and Co-Founder Announces Retirement 2
... Captivate magnetic separator for 96-well ... in conjunction with the Captivate ... or other magnetic particles and ... microplates. Cell Biology Cell Separation ...
Protein Phosphorylation...
...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
Biology Products: